Breast and Gynecologic Cancer Clinical Trials

Title	Intervention	NCT ID	Sponsor	Status
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk	Metformin, Placebo	NCT02028221	University of Arizona	Active, not recruiting
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy	Telapristone Acetate, Placebo, Laboratory Biomarker Analysis, Questionnaire Administration	NCT02314156	Northwestern University	Active, not recruiting
Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger...	Laboratory Biomarker Analysis, Recombinant Human Papillomavirus Nonavalent Vaccine	NCT02568566	National Cancer Institute (NCI)	Active, not recruiting
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II...	Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery, Placebo Administration	NCT02598557	National Cancer Institute (NCI)	Active, not recruiting
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer	Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim, Surgical Procedure	NCT02636582	National Cancer Institute (NCI)	Active, not recruiting
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive,...	Laboratory Biomarker Analysis, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine, Sargramostim	NCT02780401	University of Washington	Active, not recruiting
Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer	Retinoid 9cUAB30, Therapeutic Conventional Surgery	NCT02876640	National Cancer Institute (NCI)	Recruiting
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to...	Afimoxifene, Laboratory Biomarker Analysis, Placebo, Tamoxifen Citrate	NCT02993159	Northwestern University	Recruiting
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients	Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine	NCT03036930	National Cancer Institute (NCI)	Active, not recruiting
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast	Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration	NCT03063619	M.D. Anderson Cancer Center	Recruiting

Pages